Sr. VP of Clinical DevelopmentCIK 0002019992
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Huang Michael F.Sr. VP of Clinical Development |  SLNOSOLENO THERAPEUTICS INCDisposition to issuer | D | — 110.0K sh | May 18, 2026 traded May 18, 2026 | |
Huang Michael F.Sr. VP of Clinical Development |
| SLNOSOLENO THERAPEUTICS INC Disposition to issuer |
| D |
| — 39.8K sh |
| May 18, 2026 traded May 18, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Disposition to issuer | D | — 13.8K sh | May 18, 2026 traded May 18, 2026 |
| 5 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Disposition to issuer | D | — 11.9K sh | May 18, 2026 traded May 18, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $15K 488 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Open-market sale | SELL | $57K 1,838 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 9 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Grant or award | A | — 11.9K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 17 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Grant or award | A | — 10.4K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 9 | Huang Michael F.Sr. VP of Clinical Development | SLNOSOLENO THERAPEUTICS INC Tax withholding | F | $41K 812 sh | Dec 17, 2025 traded Dec 15, 2025 |